Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy

In this hypothesis-generating study we identified multiple pre-treatment PET-CT metrics as potential predictors of OS and CSS in patients with NSCLC treated with SABR. These could aid risk-stratification and treatment individualization if validated prospectively.